Wegovy nausea treatment: managing sickness on semaglutide

Nausea from Wegovy (semaglutide) is common, typically peaks shortly after starting or after a dose increase, and usually improves within one to two weeks as your body adjusts.
Eating smaller meals, avoiding high-fat or very rich food, and staying well hydrated are the most reliably helpful practical steps according to NHS guidance.
Severe or persistent stomach pain that radiates to your back (with or without vomiting) needs urgent medical attention; this can be a sign of pancreatitis.
Side effects you experience can be reported to the MHRA via the Yellow Card scheme, and your prescriber should always know if side effects are affecting your daily life or making you want to stop treatment.

Nausea is the side effect people on Wegovy ask about most. It tends to arrive in the first few weeks, often after a dose step-up, and for most people it settles on its own within days. There are practical things that genuinely help. These are prescription-only medicines requiring clinical assessment, so any approach to managing side effects should involve your prescriber — but below you'll find what the evidence and NHS guidance say works, and the warning signs that mean you should get help quickly.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

How to ease Wegovy nausea and when it becomes a warning sign

The first few weeks: what nausea on Wegovy actually feels like

Picture this: it's day three of your first Wegovy pen, and your usual lunch turns your stomach. You're not being sick, but eating feels like a chore, and the idea of a full plate is faintly revolting. That's the experience a lot of people describe, and it maps precisely to how semaglutide works. Wegovy slows the rate at which your stomach empties, which reduces appetite but also means food lingers longer than your gut is used to. The result, particularly in the early weeks, is nausea — sometimes queasiness, sometimes something sharper.

According to the NHS medicines page for semaglutide, nausea is one of the most commonly reported side effects alongside vomiting, diarrhoea, constipation, indigestion and burping. None of that is alarming on its own. What matters is the pattern: sickness that arrives with a new dose and then fades is the expected picture. Sickness that keeps getting worse, or that arrives with severe abdominal pain, is different and needs attention.

The timing of nausea also tracks with the titration schedule. You start on 0.25 mg to let your body adjust, and the dose increases are spaced at least four weeks apart for exactly this reason. Many people find the first day or two after each step-up is the hardest, and then the edge comes off. Knowing that rhythm can make the early weeks feel more manageable rather than alarming. For a fuller picture of what to expect across the whole side-effect profile, our guide to Wegovy side effects covers the rest of the GI list in detail.

Practical things that actually reduce nausea on Wegovy

A question our prescribers hear most weeks: "Is there anything I can actually do, or do I just wait it out?" The honest answer is both. Time is the main treatment. But some habits make a real difference to how uncomfortable the waiting is.

Eat less at each sitting. Smaller portions reduce the load on a stomach that's already emptying slowly. NHS guidance specifically recommends eating small, frequent meals rather than three large ones, and avoiding food that's very fatty, spicy or rich. A full roast dinner on week two of treatment is asking for trouble. Plain, easy foods (toast, rice, boiled potatoes, crackers) tend to sit better.

Eat slowly and stop before you feel full. The fullness signal from semaglutide arrives later than the food does; overeating is easy to do before you realise it, and it makes nausea worse. Putting your fork down between bites sounds trivial; it genuinely helps.

Stay upright for at least half an hour after eating. Lying down straight after a meal worsens reflux and slows gastric emptying further. A short walk, even just around the house, is useful. Cold or room-temperature drinks tend to be better tolerated than hot ones during the worst of the nausea phase. Ginger (whether as tea, biscuits or capsules) has some evidence behind it for general nausea, though not specifically for GLP-1 medicines.

Dehydration makes everything worse. If nausea is reducing what you eat and drink, sip water consistently through the day rather than trying to drink large amounts at once. If you're vomiting enough to struggle to keep fluids down, contact your GP or prescriber. You can find more specific coping strategies in our dedicated guide to treating Wegovy nausea.

When nausea is a warning sign, not just a side effect

Most nausea on Wegovy is uncomfortable rather than dangerous. Some nausea is neither. It's worth knowing the difference before it matters.

Pancreatitis (inflammation of the pancreas) is an infrequent but potentially serious side effect associated with GLP-1 receptor agonists including semaglutide. In January 2026, the MHRA issued a Drug Safety Update specifically highlighting acute pancreatitis as a known risk with this class of medicines. The symptoms to act on are severe, persistent stomach pain that reaches through to your back, particularly if accompanied by vomiting. This is different from ordinary nausea. It doesn't resolve with ginger tea. If you experience it, stop eating and get urgent medical help: call 111 or go to A&E. You can read the MHRA's wider communications on GLP-1 safety via their Drug Safety Update index on GOV.UK.

Gallbladder problems are another category to know about. Rapid weight loss itself, independent of the medicine, can increase gallstone risk. Sudden, severe pain in the upper right of your abdomen (especially after eating) warrants a call to your GP rather than a wait-and-see approach.

Persistent vomiting that stops you keeping food and fluids down for more than 24 hours can lead to dehydration and affect kidney function. Contact your prescriber or GP if you reach that point. And if nausea or any other side effect is making you consider stopping treatment altogether, speak to our team before you do, there may be options your prescriber hasn't explored yet, and stopping and restarting carries its own considerations.

The role of your prescriber and when to report what you're experiencing

Wegovy is a prescription-only medicine. The prescriber who approves your treatment should also be your first call when side effects are affecting your life. That's not a formality, adjusting pace of titration, pausing a dose increase, or simply knowing what's within normal range versus what needs investigation: all of that requires clinical input.

If you're accessing Wegovy privately, including through an online service, your prescriber has the same duty of aftercare as any other. At nume, every repeat order is reviewed by a GPhC-registered prescriber before it's dispensed, and aftercare support runs seven days a week. Side-effect management is part of what that means. Our clinical approach is described in more detail here if you'd like to understand how we work.

Anything that feels unexpected, worsening or different from what's described in your patient information leaflet is worth reporting. The Yellow Card scheme exists so the MHRA can monitor real-world safety signals for medicines like Wegovy, and your report genuinely contributes to that picture. You don't need a diagnosis to report, a suspicion is enough. Some people also notice other changes while on treatment, and if you've been experiencing hair loss alongside other Wegovy side effects, that's something our prescribers can discuss with you too. Side effects from semaglutide on the injection side sit alongside a related question many people have about oral treatment; if you're weighing up the two, our Wegovy overview covers both formats and what the differences mean in practice.

If you're still deciding whether Wegovy is right for you, or you'd like our prescribers to talk through your specific circumstances (including how side effects tend to present at your starting dose) starting a free consultation is the place to begin. Suitability, side effects and your medical history are all part of what that conversation covers. If constipation is among the symptoms you want to understand better, our guide to managing constipation on semaglutide is a useful starting point before that conversation.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions